Prot #NU 21N05: A Phase II, Multicenter Study of XmAb20717 in Patients with Metastatic Anaplastic Thyroid Cancer with an Exploratory Cohort in Aggressive Hurthle Cell Thyroid Cancer

Project: Research project

Project Details

StatusActive
Effective start/end date5/6/22 → 5/6/25

Funding

  • Xencor, Inc. ((OE) Prot #NU 21N05)